Michael D. Lubeck
- Molecular Biology top 10%
- Immunology top 5%
- Epidemiology top 5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Genetics top 5%
- Co-authors
- Hilary KoprowskiZenon SteplewskiWalter GerhardPeter PaleseJerome L. SchulmanDorothee HerlynSatoshi MizutaniHenry F. Sears
- Topics
- Virus-based gene therapy research (22 papers)Monoclonal and Polyclonal Antibodies Research (19 papers)Glycosylation and Glycoproteins Research (14 papers)
- Partner nations
- United StatesCanadaRussia
In The Last Decade
Michael D. Lubeck
49 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 1.0k
- Immunology 798
- Epidemiology 754
- Radiology, Nuclear Medicine and Imaging 728
- Genetics 672
Countries citing papers authored by Michael D. Lubeck
This map shows the geographic impact of Michael D. Lubeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Lubeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Lubeck more than expected).
Fields of papers citing papers by Michael D. Lubeck
This network shows the impact of papers produced by Michael D. Lubeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Lubeck. The network helps show where Michael D. Lubeck may publish in the future.
Co-authorship network of co-authors of Michael D. Lubeck
This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Lubeck. A scholar is included among the top collaborators of Michael D. Lubeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Lubeck. Michael D. Lubeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 90 | |
| 2 | 7 | |
| 3 | 14 | |
| 4 | 15 | |
| 5 | 64 | |
| 6 | 39 | |
| 7 | 56 | |
| 8 | 61 | |
| 9 | 43 | |
| 10 | 11 | |
| 11 | 14 | |
| 12 | 33 | |
| 13 | 23 | |
| 14 | 6 | |
| 15 | 31 | |
| 16 | 32 | |
| 17 | 18 | |
| 18 | 37 | |
| 19 | Anti-idiotypic antibodies to monoclonal antibody CO17-1A. | 33 |
| 20 | 3 |
About Michael D. Lubeck
Michael D. Lubeck is a scholar working on Virology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 49 papers that have together received 2.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (22 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and Glycosylation and Glycoproteins Research (14 papers). The work is most often cited by research in Virology (370 citations), Immunology (798 citations) and Radiology, Nuclear Medicine and Imaging (728 citations). Michael D. Lubeck has collaborated with scholars based in United States, Canada and Russia. Frequent co-authors include Hilary Koprowski, Zenon Steplewski, Walter Gerhard, Peter Palese, Jerome L. Schulman, Dorothee Herlyn, Satoshi Mizutani, Henry F. Sears, P.P. Hung and Bheem M. Bhat. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.